Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design
G protein-coupled receptors (GPCRs) are a critical target in modern drug development across a wide range of indications. Here the authors provide a comprehensive characterization of a typical GPCR, the angiotensin II (AngII) type 1 receptor (AT1R), and provide insight into its activation mechanism t...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac9008e70a2947a995418dd644c36965 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ac9008e70a2947a995418dd644c36965 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ac9008e70a2947a995418dd644c369652021-12-02T16:35:46ZActivation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design10.1038/s41467-021-25020-92041-1723https://doaj.org/article/ac9008e70a2947a995418dd644c369652021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25020-9https://doaj.org/toc/2041-1723G protein-coupled receptors (GPCRs) are a critical target in modern drug development across a wide range of indications. Here the authors provide a comprehensive characterization of a typical GPCR, the angiotensin II (AngII) type 1 receptor (AT1R), and provide insight into its activation mechanism that suggest avenues for the design of allosteric GPCR modulators.Shaoyong LuXinheng HeZhao YangZongtao ChaiShuhua ZhouJunyan WangAshfaq Ur RehmanDuan NiJun PuJinpeng SunJian ZhangNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Shaoyong Lu Xinheng He Zhao Yang Zongtao Chai Shuhua Zhou Junyan Wang Ashfaq Ur Rehman Duan Ni Jun Pu Jinpeng Sun Jian Zhang Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design |
description |
G protein-coupled receptors (GPCRs) are a critical target in modern drug development across a wide range of indications. Here the authors provide a comprehensive characterization of a typical GPCR, the angiotensin II (AngII) type 1 receptor (AT1R), and provide insight into its activation mechanism that suggest avenues for the design of allosteric GPCR modulators. |
format |
article |
author |
Shaoyong Lu Xinheng He Zhao Yang Zongtao Chai Shuhua Zhou Junyan Wang Ashfaq Ur Rehman Duan Ni Jun Pu Jinpeng Sun Jian Zhang |
author_facet |
Shaoyong Lu Xinheng He Zhao Yang Zongtao Chai Shuhua Zhou Junyan Wang Ashfaq Ur Rehman Duan Ni Jun Pu Jinpeng Sun Jian Zhang |
author_sort |
Shaoyong Lu |
title |
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design |
title_short |
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design |
title_full |
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design |
title_fullStr |
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design |
title_full_unstemmed |
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design |
title_sort |
activation pathway of a g protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ac9008e70a2947a995418dd644c36965 |
work_keys_str_mv |
AT shaoyonglu activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT xinhenghe activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT zhaoyang activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT zongtaochai activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT shuhuazhou activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT junyanwang activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT ashfaqurrehman activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT duanni activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT junpu activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT jinpengsun activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign AT jianzhang activationpathwayofagproteincoupledreceptoruncoversconformationalintermediatesastargetsforallostericdrugdesign |
_version_ |
1718383711931596800 |